Medtronic Inc (MDT) News $MDT
St. Jude Sparks Hope for a Pain-Free Future
Dan Carroll, The Motley Fool - Motley Fool - Fri Mar 21, 5:30PM CDT
The medical tech industry has endured a rough ride in the wake of the recession, but you wouldn't know it by looking at the stock charts of leading device companies over the past year. St. Jude Medical is among the most notable names in that...
Final Glance: Medical Devices companies
AP - Fri Mar 21, 5:03PM CDT
NEW YORK (AP) — Shares of some top medical devices companies were mixed at the close of trading:
Watch for Medtronic to Potentially Rebound After Falling 1.26% Yesterday
Comtex SmarTrend(R) - Fri Mar 21, 4:13PM CDT
Medtronic (NYSE:MDT) traded in a range yesterday that spanned from a low of $58.66 to a high of $60.38. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $59.17 on volume of 7.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Look for Shares of Medtronic to Potentially Rebound after Yesterday's 1.26% Sell Off
Comtex SmarTrend(R) - Fri Mar 21, 4:08PM CDT
Medtronic (NYSE:MDT) traded in a range yesterday that spanned from a low of $58.66 to a high of $60.38. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $59.17 on volume of 7.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Midday Glance: Medical Devices companies
AP - Fri Mar 21, 12:24PM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 1 p.m.:
Global Cardiac Pacemaker Market 2014-2018: Increasing Use of MEMS-built Pacemakers a Major Trend
M2 - Fri Mar 21, 9:50AM CDT
Research and Markets (http://www.researchandmarkets.com/research/6tmqq2/global_cardiac) has announced the addition of the "Global Cardiac Pacemaker Market 2014-2018" report to their offering. The analysts forecast the Global Cardiac Pacemakers market will grow at a CAGR of 13.83 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing incidence of cardiac disorders. The Global Cardiac Pacemakers market has also been witnessing the development of leadless pacemakers. However, the presence of substitutes for cardiac pacemakers could pose a challenge to the growth of this market. The key vendors dominating this space are BIOTRONIK Inc., Boston Scientific Corp., Medtronic Inc., St. Jude Medical Inc., and SORIN S.p.A. The other vendors mentioned in the report are Cook Medical Inc., CCC Medical Devices, and Medico S.p.A. Commenting on the report, an analyst from the team said: The increasing use of MEMS in cardiac pacemakers is one the major trends in the Global Cardiac Pacemakers market. MEMS make use of micro-fabrication techniques to create integrated circuits that produce smaller and more controllable devices. MEMS-built pacemakers are cheaper and less invasive. The pacemakers currently available in the market employ MEMS accelerometers, which are capable of adjusting the heart rate in accordance with physical activity. According to the report, one of the major drivers in this market is the increasing incidence of cardiac disorders. Cardiac disorders include bradycardia, sick sinus syndrome, atrioventricular blocks, cardiac arrest, and tachycardia, all of which have increased the demand for pacemakers. Further, the report states that one of the major challenges in the market is the presence of substitutes such as cardiac ablation catheters, which are used to destroy the diseased area with abnormal heart rhythm, and implantable cardioverter-defibrillators, which are used for tachycardia management. For more information visit http://www.researchandmarkets.com/research/6t...al_cardiac About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Early Glance: Medical Devices companies
AP - Fri Mar 21, 9:46AM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 10 a.m.:
Japan Spinal Surgery Market Outlook to 2020
M2 - Fri Mar 21, 5:35AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3636df/japan_spinal) has announced the addition of the "Japan Spinal Surgery Market Outlook to 2020" report to their offering. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Spinal Fusion and Vertebral Compression Fracture Repair Devices. The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Spinal Surgery market wherever available. Scope - Market size for Spinal Surgery market categories. - Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2005 to 2012 and forecast to 2020. - 2012 company shares and distribution shares data for each of the market categories. - Global corporate-level profiles of key companies operating within the market. Reasons to Buy - Develop business strategies by identifying the key market segments poised for strong growth in the future. - Develop market-entry and market expansion strategies. - Design competition strategies by identifying who-stands-where in the market. - Develop investment strategies by identifying the key market segments expected to register strong growth in the near future. Key Topics Covered 1 Table of Contents 2 Introduction 3 Spinal Surgery Market, Japan 3.1 Revenue ($m), 2005-2012 3.2 Revenue ($m), 2012-2020 3.3 Volume (Units), 2005-2012 3.4 Volume (Units), 2012-2020 3.5 Average Price ($), 2005-2020 3.6 Distribution Share by Revenue ($m), 2011-2012 3.7 Company Share by Revenue ($m), 2011-2012 4 Overview of Key Companies in Japan Spinal Surgery Market 5 Spinal Surgery Market Pipeline Products 6 Financial Deals Landscape 7 Recent Developments 8 Appendix Companies Mentioned - Alphatec - B. Braun Melsungen - Biomet - DePuy - Japan Medical Dynamic Marketing - Medtronic - Orthofix International - Stryker - Zimmer For more information visit http://www.researchandmarkets.com/research/36...pan_spinal About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.
Global Vascular Stents Market 2012-2016: Drivers, Challenges and Trends
M2 - Thu Mar 20, 11:05AM CDT
Research and Markets (http://www.researchandmarkets.com/research/t434wn/global_vascular) has announced the addition of the "Global Vascular Stents Market 2012-2016" report to their offering. The analysts forecast the Global Vascular Stents Market to grow at a CAGR of 8.21 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing prevalence of cardiovascular disease. The Global Vascular Stents Market has also been witnessing the trend of increasing demand for minimally invasive procedures. However, availability of alternative therapies could pose a challenge to the growth of this market. Key vendors dominating this space Abbott Laboratories, Medtronic Inc., Boston Scientific Corp., and Cordis Corp. Other vendors mentioned in the report are MicroPort Scientific Corp., Cook Medical, Biosensors International Ltd., and B. Braun Melsungen AG, Allvivo Vascular Inc., Arterial Remodeling Technologies, Biocompatibles Ltd., Biotronik KG, Blue Medical, Cook Medical Inc., Devax Inc., Endovasc Inc., Goodman Co. Ltd., InnoCore Technologies BV, MIV Therapeutics Inc., Reva Medical Inc., Stentys SA, SurModics Inc., Translumina GmbH, X-Cell Medical Inc. and Xtent Inc. Commenting on the report, an analyst from the Healthcare team said: ''There is an increasing demand for minimally invasive surgery among the rapidly increasing aging population across the world, and this is expected to propel the growth of the Global Vascular Stents market. Minimally invasive endovascular procedures are performed through minute incisions in the body. Such procedures can be used to treat plaque blockages in the arteries of the heart and other vessel walls of peripheral organs such as the kidneys and the brain. The principal advantage of these procedures over conventional surgical methods is the short recovery time, short length of the scars resulting in less physical trauma, low risk of infection, minimized bleeding, low cost, and shorter hospital stays.'' According to the report, one of the key drivers is the increase in the number of patients suffering from CVD. Unhealthy diet and lack of physical activity are the major factors leading to an increase in the number of people prone to CVD. For more information visit http://www.researchandmarkets.com/research/t4...l_vascular About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
MediPoint: Electrophysiology - APAC Analysis and Market Forecasts to 2020
M2 - Thu Mar 20, 10:22AM CDT
Research and Markets (http://www.researchandmarkets.com/research/z8kgmv/medipoint) has announced the addition of the "MediPoint: Electrophysiology - APAC Analysis and Market Forecasts" report to their offering. Still in its infancy, the electrophysiology (EP) device market has seen significant adoption; as more physicians become experienced in diagnostic and ablation techniques, increasing numbers of hospitals purchase supportive equipment, device price-points fall, and efficacy improves. This continued growth is also driven by technological advancements including the emergence of next-generation ablation technologies, improvements in catheter diagnostics, and advancements in lab systems. Further, as imaging modalities improve, patients are exposed to less radiation than ever before, which will only further drive diagnostics. Growth in emerging markets is expected to drive sales as developing countries look to implement new EP programs, and hospitals adopt ablation techniques. Lastly, published studies, clinical evidence, and patient awareness will all contribute positively to EP market growth and will provide further evidence of the effectiveness of cardiac catheter ablation. Scope - An overview of electrophysiology, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines. - Annualized APAC electrophysiology market revenue from 2005 to 2013, forecast for 7 years to 2020. - Investigation of current and future market competition for electrophysiology - Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events. - Competitor assessment including device approval analysis and device sales forecasts. - Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast. - Analysis of unmet needs within the market and opportunities for future players. - Technology trends evaluation to assess strength of pipeline. - An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines. - Company profiles including business description, financial overview and SWOT analysis. - Coverage of key market players. - Strategic assessment of the electrophysiology sector through market impact analysis, future market scenario and company analysis. - Direct quotes from Key Opinion Leaders (KOL) Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Industry Overview 4 Segment Analysis 5 Market Outlooks by Geography 6 Strategic Competitive Assessment 7 Current and Future Players 8 Pipeline Product Assessment 9 Strategic Deals Analysis 10 Appendix Companies Mentioned - Biosense Webster - Biotronik - Boston Scientific - CardioFocus - CardioInsight - Hansen Medical - Imricor - Japan Lifeline - Magnetecs Corporation - Medtronic - MicroPort Scientific Company - St. Jude Medical - Stereotaxis - Stryker Sustainability Solutions - Topera Medical For more information visit http://www.researchandmarkets.com/research/z8kgmv/medipoint
Bad News Buy: Intuitive Surgical vs. Edwards Lifesciences
Dan Carroll, The Motley Fool - Motley Fool - Thu Mar 20, 8:30AM CDT
It's been a rough year for robotic surgical system maker Intuitive Surgical . This innovative company might lead the up-and-coming robot revolution in health care, but its shares have felt the pain over the past year, falling more than 9% over that...
Market Research: France Orthobiologics Market Outlook to 2020
M2 - Thu Mar 20, 3:26AM CDT
Research and Markets (http://www.researchandmarkets.com/research/37gx6q/france) has announced the addition of the "France Orthobiologics Market Outlook to 2020" report to their offering. "France Orthobiologics Market Outlook to 2020", provides key market data on the France Orthobiologics market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Bone Graft Substitutes, Viscosupplementation, Bone Allografts and Bone Growth Stimulators. The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Orthobiologics market wherever available. The data in the report is derived from dynamic market forecast models. The authors use epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases). Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. Scope - Market size for Orthobiologics market categories - Bone Graft Substitutes, Viscosupplementation, Bone Allografts and Bone Growth Stimulators. - Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2005 to 2012 and forecast to 2020. - 2012 company shares and distribution shares data for each of the market categories. - Global corporate-level profiles of key companies operating within the France Orthobiologics market. Key Topics Covered: List of Tables List of Figures Introduction Orthobiologics Market, France Overview of Key Companies in France Orthobiologics Market Orthobiologics Market Pipeline Products Financial Deals Landscape Recent Developments Appendix List of Tables List of Figures Companies Mentioned Medtronic, Inc. DePuy Companies Biomet, Inc. Stryker Corporation Baxter International Inc. Sanofi DJO Finance LLC Anika Therapeutics, Inc. Ferring International Center S.A. Wright Medical Group, Inc. Globus Medical, Inc. Orthofix International N.V. Seikagaku Corporation For more information visit http://www.researchandmarkets.com/research/37gx6q/france About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Texas Cardiac Arrhythmia Institute at St. David's Medical Center Among First in United States to Use Miniature Cardiac Monitor, Reveal LINQ(TM) ICM
PR Newswire - Wed Mar 19, 5:26PM CDT
On Feb. 27, 2014, Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center was among the first in the United States to implant the Medtronic Reveal LINQ Insertable Cardiac Monitor (ICM) System in a patient. The Reveal LINQ ICM is the smallest implantable cardiac monitoring device available. The procedure was performed by Andrea Natale, M.D., F.H.R.S., F.A.C.C., F.E.S.C., cardiac electrophysiologist and executive medical director of TCAI.
Boston Scientific Advances in Europe - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 19, 4:45PM CDT
Boston Scientific announced CE Mark approval and the launch of its INGEVITY family of MRI compatible pacing leads in Europe.
Global Neurostimulation Devices Market 2012-2016: Challenges Explained
M2 - Wed Mar 19, 9:48AM CDT
Research and Markets (http://www.researchandmarkets.com/research/dkdftd/global) has announced the addition of the "Global Neurostimulation Devices Market 2012-2016" report to their offering. TechNavio's analysts forecast the Global Neurostimulation Devices market to grow at a CAGR of 15.3 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing prevalence of neurological disorders. The Global Neurostimulation Devices market has also been witnessing an increasing demand for minimally invasive procedures to treat neurological disorders. However, the availability of alternative drug therapy could pose a challenge to the growth of this market. The key vendors dominating this space are Medtronic Inc., St. Jude Medical Inc., Boston Scientific Corp., and Cyberonics Inc. The other vendors mentioned in the report are Afferent Corp., Cyberkinetics Neurotechnology Systems Inc., Synapse Biomedical Inc., SPR Therapeutics LLC, NeuroVista Corp., and Neuros Medical Inc. Commenting on the report, an analyst from TechNavio's Healthcare team said:'An increasing demand for minimally invasive devices has been noticed among members of the rapidly aging population across the world, and this is expected to spark the growth of the Global Neurostimulation Devices market. This is because minimally invasive surgery causes less pain, reduces the duration of the recovery process, causes minimal injuries, has a low risk of infection, and minimizes bleeding. Moreover, less invasive methods are cost efficient when compared to invasive methods, and this is expected to increase the demand for them in the near future. This trend will have a positive impact on the growth of the market.' According to the report, one of the major factors driving the market is the growth of the patient population in terms of epilepsy, depression, stroke, anxiety disorders, and Parkinson's disease, which increases the demand for neurostimulation devices as neurostimulation is considered to be a more effective and safer therapy. For more information visit http://www.researchandmarkets.com/research/dkdftd/global About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
St. Jude Sparks Hope for a Pain-Free Future
Dan Carroll, The Motley Fool - Motley Fool - Fri Mar 21, 5:30PM CDT
The medical tech industry has endured a rough ride in the wake of the recession, but you wouldn't know it by looking at the stock charts of leading device companies over the past year. St. Jude Medical is among the most notable names in that...
Final Glance: Medical Devices companies
AP - Fri Mar 21, 5:03PM CDT
NEW YORK (AP) — Shares of some top medical devices companies were mixed at the close of trading:
Watch for Medtronic to Potentially Rebound After Falling 1.26% Yesterday
Comtex SmarTrend(R) - Fri Mar 21, 4:13PM CDT
Medtronic (NYSE:MDT) traded in a range yesterday that spanned from a low of $58.66 to a high of $60.38. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $59.17 on volume of 7.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Look for Shares of Medtronic to Potentially Rebound after Yesterday's 1.26% Sell Off
Comtex SmarTrend(R) - Fri Mar 21, 4:08PM CDT
Medtronic (NYSE:MDT) traded in a range yesterday that spanned from a low of $58.66 to a high of $60.38. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $59.17 on volume of 7.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Midday Glance: Medical Devices companies
AP - Fri Mar 21, 12:24PM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 1 p.m.:
Global Cardiac Pacemaker Market 2014-2018: Increasing Use of MEMS-built Pacemakers a Major Trend
M2 - Fri Mar 21, 9:50AM CDT
Research and Markets (http://www.researchandmarkets.com/research/6tmqq2/global_cardiac) has announced the addition of the "Global Cardiac Pacemaker Market 2014-2018" report to their offering. The analysts forecast the Global Cardiac Pacemakers market will grow at a CAGR of 13.83 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing incidence of cardiac disorders. The Global Cardiac Pacemakers market has also been witnessing the development of leadless pacemakers. However, the presence of substitutes for cardiac pacemakers could pose a challenge to the growth of this market. The key vendors dominating this space are BIOTRONIK Inc., Boston Scientific Corp., Medtronic Inc., St. Jude Medical Inc., and SORIN S.p.A. The other vendors mentioned in the report are Cook Medical Inc., CCC Medical Devices, and Medico S.p.A. Commenting on the report, an analyst from the team said: The increasing use of MEMS in cardiac pacemakers is one the major trends in the Global Cardiac Pacemakers market. MEMS make use of micro-fabrication techniques to create integrated circuits that produce smaller and more controllable devices. MEMS-built pacemakers are cheaper and less invasive. The pacemakers currently available in the market employ MEMS accelerometers, which are capable of adjusting the heart rate in accordance with physical activity. According to the report, one of the major drivers in this market is the increasing incidence of cardiac disorders. Cardiac disorders include bradycardia, sick sinus syndrome, atrioventricular blocks, cardiac arrest, and tachycardia, all of which have increased the demand for pacemakers. Further, the report states that one of the major challenges in the market is the presence of substitutes such as cardiac ablation catheters, which are used to destroy the diseased area with abnormal heart rhythm, and implantable cardioverter-defibrillators, which are used for tachycardia management. For more information visit http://www.researchandmarkets.com/research/6t...al_cardiac About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Early Glance: Medical Devices companies
AP - Fri Mar 21, 9:46AM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 10 a.m.:
Japan Spinal Surgery Market Outlook to 2020
M2 - Fri Mar 21, 5:35AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3636df/japan_spinal) has announced the addition of the "Japan Spinal Surgery Market Outlook to 2020" report to their offering. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Spinal Fusion and Vertebral Compression Fracture Repair Devices. The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Spinal Surgery market wherever available. Scope - Market size for Spinal Surgery market categories. - Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2005 to 2012 and forecast to 2020. - 2012 company shares and distribution shares data for each of the market categories. - Global corporate-level profiles of key companies operating within the market. Reasons to Buy - Develop business strategies by identifying the key market segments poised for strong growth in the future. - Develop market-entry and market expansion strategies. - Design competition strategies by identifying who-stands-where in the market. - Develop investment strategies by identifying the key market segments expected to register strong growth in the near future. Key Topics Covered 1 Table of Contents 2 Introduction 3 Spinal Surgery Market, Japan 3.1 Revenue ($m), 2005-2012 3.2 Revenue ($m), 2012-2020 3.3 Volume (Units), 2005-2012 3.4 Volume (Units), 2012-2020 3.5 Average Price ($), 2005-2020 3.6 Distribution Share by Revenue ($m), 2011-2012 3.7 Company Share by Revenue ($m), 2011-2012 4 Overview of Key Companies in Japan Spinal Surgery Market 5 Spinal Surgery Market Pipeline Products 6 Financial Deals Landscape 7 Recent Developments 8 Appendix Companies Mentioned - Alphatec - B. Braun Melsungen - Biomet - DePuy - Japan Medical Dynamic Marketing - Medtronic - Orthofix International - Stryker - Zimmer For more information visit http://www.researchandmarkets.com/research/36...pan_spinal About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.
Global Vascular Stents Market 2012-2016: Drivers, Challenges and Trends
M2 - Thu Mar 20, 11:05AM CDT
Research and Markets (http://www.researchandmarkets.com/research/t434wn/global_vascular) has announced the addition of the "Global Vascular Stents Market 2012-2016" report to their offering. The analysts forecast the Global Vascular Stents Market to grow at a CAGR of 8.21 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing prevalence of cardiovascular disease. The Global Vascular Stents Market has also been witnessing the trend of increasing demand for minimally invasive procedures. However, availability of alternative therapies could pose a challenge to the growth of this market. Key vendors dominating this space Abbott Laboratories, Medtronic Inc., Boston Scientific Corp., and Cordis Corp. Other vendors mentioned in the report are MicroPort Scientific Corp., Cook Medical, Biosensors International Ltd., and B. Braun Melsungen AG, Allvivo Vascular Inc., Arterial Remodeling Technologies, Biocompatibles Ltd., Biotronik KG, Blue Medical, Cook Medical Inc., Devax Inc., Endovasc Inc., Goodman Co. Ltd., InnoCore Technologies BV, MIV Therapeutics Inc., Reva Medical Inc., Stentys SA, SurModics Inc., Translumina GmbH, X-Cell Medical Inc. and Xtent Inc. Commenting on the report, an analyst from the Healthcare team said: ''There is an increasing demand for minimally invasive surgery among the rapidly increasing aging population across the world, and this is expected to propel the growth of the Global Vascular Stents market. Minimally invasive endovascular procedures are performed through minute incisions in the body. Such procedures can be used to treat plaque blockages in the arteries of the heart and other vessel walls of peripheral organs such as the kidneys and the brain. The principal advantage of these procedures over conventional surgical methods is the short recovery time, short length of the scars resulting in less physical trauma, low risk of infection, minimized bleeding, low cost, and shorter hospital stays.'' According to the report, one of the key drivers is the increase in the number of patients suffering from CVD. Unhealthy diet and lack of physical activity are the major factors leading to an increase in the number of people prone to CVD. For more information visit http://www.researchandmarkets.com/research/t4...l_vascular About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
MediPoint: Electrophysiology - APAC Analysis and Market Forecasts to 2020
M2 - Thu Mar 20, 10:22AM CDT
Research and Markets (http://www.researchandmarkets.com/research/z8kgmv/medipoint) has announced the addition of the "MediPoint: Electrophysiology - APAC Analysis and Market Forecasts" report to their offering. Still in its infancy, the electrophysiology (EP) device market has seen significant adoption; as more physicians become experienced in diagnostic and ablation techniques, increasing numbers of hospitals purchase supportive equipment, device price-points fall, and efficacy improves. This continued growth is also driven by technological advancements including the emergence of next-generation ablation technologies, improvements in catheter diagnostics, and advancements in lab systems. Further, as imaging modalities improve, patients are exposed to less radiation than ever before, which will only further drive diagnostics. Growth in emerging markets is expected to drive sales as developing countries look to implement new EP programs, and hospitals adopt ablation techniques. Lastly, published studies, clinical evidence, and patient awareness will all contribute positively to EP market growth and will provide further evidence of the effectiveness of cardiac catheter ablation. Scope - An overview of electrophysiology, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines. - Annualized APAC electrophysiology market revenue from 2005 to 2013, forecast for 7 years to 2020. - Investigation of current and future market competition for electrophysiology - Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events. - Competitor assessment including device approval analysis and device sales forecasts. - Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast. - Analysis of unmet needs within the market and opportunities for future players. - Technology trends evaluation to assess strength of pipeline. - An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines. - Company profiles including business description, financial overview and SWOT analysis. - Coverage of key market players. - Strategic assessment of the electrophysiology sector through market impact analysis, future market scenario and company analysis. - Direct quotes from Key Opinion Leaders (KOL) Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Industry Overview 4 Segment Analysis 5 Market Outlooks by Geography 6 Strategic Competitive Assessment 7 Current and Future Players 8 Pipeline Product Assessment 9 Strategic Deals Analysis 10 Appendix Companies Mentioned - Biosense Webster - Biotronik - Boston Scientific - CardioFocus - CardioInsight - Hansen Medical - Imricor - Japan Lifeline - Magnetecs Corporation - Medtronic - MicroPort Scientific Company - St. Jude Medical - Stereotaxis - Stryker Sustainability Solutions - Topera Medical For more information visit http://www.researchandmarkets.com/research/z8kgmv/medipoint
Bad News Buy: Intuitive Surgical vs. Edwards Lifesciences
Dan Carroll, The Motley Fool - Motley Fool - Thu Mar 20, 8:30AM CDT
It's been a rough year for robotic surgical system maker Intuitive Surgical . This innovative company might lead the up-and-coming robot revolution in health care, but its shares have felt the pain over the past year, falling more than 9% over that...
Market Research: France Orthobiologics Market Outlook to 2020
M2 - Thu Mar 20, 3:26AM CDT
Research and Markets (http://www.researchandmarkets.com/research/37gx6q/france) has announced the addition of the "France Orthobiologics Market Outlook to 2020" report to their offering. "France Orthobiologics Market Outlook to 2020", provides key market data on the France Orthobiologics market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Bone Graft Substitutes, Viscosupplementation, Bone Allografts and Bone Growth Stimulators. The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Orthobiologics market wherever available. The data in the report is derived from dynamic market forecast models. The authors use epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases). Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. Scope - Market size for Orthobiologics market categories - Bone Graft Substitutes, Viscosupplementation, Bone Allografts and Bone Growth Stimulators. - Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2005 to 2012 and forecast to 2020. - 2012 company shares and distribution shares data for each of the market categories. - Global corporate-level profiles of key companies operating within the France Orthobiologics market. Key Topics Covered: List of Tables List of Figures Introduction Orthobiologics Market, France Overview of Key Companies in France Orthobiologics Market Orthobiologics Market Pipeline Products Financial Deals Landscape Recent Developments Appendix List of Tables List of Figures Companies Mentioned Medtronic, Inc. DePuy Companies Biomet, Inc. Stryker Corporation Baxter International Inc. Sanofi DJO Finance LLC Anika Therapeutics, Inc. Ferring International Center S.A. Wright Medical Group, Inc. Globus Medical, Inc. Orthofix International N.V. Seikagaku Corporation For more information visit http://www.researchandmarkets.com/research/37gx6q/france About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Texas Cardiac Arrhythmia Institute at St. David's Medical Center Among First in United States to Use Miniature Cardiac Monitor, Reveal LINQ(TM) ICM
PR Newswire - Wed Mar 19, 5:26PM CDT
On Feb. 27, 2014, Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center was among the first in the United States to implant the Medtronic Reveal LINQ Insertable Cardiac Monitor (ICM) System in a patient. The Reveal LINQ ICM is the smallest implantable cardiac monitoring device available. The procedure was performed by Andrea Natale, M.D., F.H.R.S., F.A.C.C., F.E.S.C., cardiac electrophysiologist and executive medical director of TCAI.
Boston Scientific Advances in Europe - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 19, 4:45PM CDT
Boston Scientific announced CE Mark approval and the launch of its INGEVITY family of MRI compatible pacing leads in Europe.
Global Neurostimulation Devices Market 2012-2016: Challenges Explained
M2 - Wed Mar 19, 9:48AM CDT
Research and Markets (http://www.researchandmarkets.com/research/dkdftd/global) has announced the addition of the "Global Neurostimulation Devices Market 2012-2016" report to their offering. TechNavio's analysts forecast the Global Neurostimulation Devices market to grow at a CAGR of 15.3 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing prevalence of neurological disorders. The Global Neurostimulation Devices market has also been witnessing an increasing demand for minimally invasive procedures to treat neurological disorders. However, the availability of alternative drug therapy could pose a challenge to the growth of this market. The key vendors dominating this space are Medtronic Inc., St. Jude Medical Inc., Boston Scientific Corp., and Cyberonics Inc. The other vendors mentioned in the report are Afferent Corp., Cyberkinetics Neurotechnology Systems Inc., Synapse Biomedical Inc., SPR Therapeutics LLC, NeuroVista Corp., and Neuros Medical Inc. Commenting on the report, an analyst from TechNavio's Healthcare team said:'An increasing demand for minimally invasive devices has been noticed among members of the rapidly aging population across the world, and this is expected to spark the growth of the Global Neurostimulation Devices market. This is because minimally invasive surgery causes less pain, reduces the duration of the recovery process, causes minimal injuries, has a low risk of infection, and minimizes bleeding. Moreover, less invasive methods are cost efficient when compared to invasive methods, and this is expected to increase the demand for them in the near future. This trend will have a positive impact on the growth of the market.' According to the report, one of the major factors driving the market is the growth of the patient population in terms of epilepsy, depression, stroke, anxiety disorders, and Parkinson's disease, which increases the demand for neurostimulation devices as neurostimulation is considered to be a more effective and safer therapy. For more information visit http://www.researchandmarkets.com/research/dkdftd/global About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
